Immunization strategies to block the herpes simplex virus type 1 immunoglobulin G Fc receptor.
D000818:Animals; D000914:Antibodies, Viral / Q000276:immunology* / Q000494:pharmacology; D016367:Baculoviridae / Q000235:genetics; D001667:Binding, Competitive; D019556:COS Cells; D005434:Flow Cytometry; D022301:Herpes Simplex Virus Vaccines / Q000235:genetics / Q000276:immunology; D018259:Herpesvirus 1, Human / Q000187:drug effects / Q000235:genetics / Q000276:immunology*; D006801:Humans; D007114:Immunization; D007074:Immunoglobulin G / Q000276:immunology; D051379:Mice; D011817:Rabbits; D017452:Receptors, IgG / Q000037:antagonists & inhibitors / Q000235:genetics / Q000276:immunology*; D014759:Viral Envelope Proteins / Q000037:antagonists & inhibitors / Q000235:genetics / Q000276:immunology* / Q000494:pharmacology
D000914:Antibodies, Viral; D022301:Herpes Simplex Virus Vaccines; D007074:Immunoglobulin G; D017452:Receptors, IgG; D014759:Viral Envelope Proteins; C039447:glycoprotein D, Human herpesvirus 1; C044768:glycoprotein E, herpes simplex virus type 1; C038535:glycoprotein gC, herpes simplex virus type 1